Cannabis and Pregnancy

Tuesday, January 30, 2024, 12:30 PM - 1:30 PM

There is no cost to attend this education.

 

Virtual Event:
By registering for the virtual activity, you will be able to view presentations, hear live audio, and interact online. This virtual activity will be fully web-based, and you will need a computer/laptop or tablet, audio and an internet connection.  WebEx can be accessed from any computer - both on and off the Avera network.   Details will be emailed to all attendees before the activity. Please be aware that you are not authorized to record, copy or share content in any manner.

The Avera Research Institute of Maternal Health Research Center of Excellence (MARCH) provides a platforms a platform for researchers, tribal nations, rural communities, and key stakeholders to engage in bidirectional communication on maternal health, in particular drivers of mortality and severe morbidity. This Avera Live Webinar session about "Cannabis and Pregnancy" is part of the Avera Research Institute, MARCH Center of Excellence training for enhancing knowledge and skills for investigators and community partners to conduct research and improve health care for women.

1. Integrate a multidiciplinary approach into the development of plan of care.
2. Identify practice related quality and safety issues.
3. Discuss cultural appropriate practices in rural and minority communities, particularly American Indian communities.
4. Discuss and analyze team barriers that could impede patient care.
5. Identify strategies in a collaborative team approach to prevent and manage complications related to maternal mortality and morbidity.

This education opportunity is provided by the Avera Research Institute, Maternal American Indian Rural Community Health Center of Excellence and is supported by grant award [U54-HD113179, PI: Elliott]. The MARCH Center of Excellence provides a platform for researchers, tribal nations, rural communities, and key stakeholders to engage in bidirectional communication on maternal health. Contact Avera Research Institute at [email protected] email or 605-504-3154 phone number with questions.

In support of improving patient care, Avera is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designations:

	IPCE (Team-based): This activity was planned by and for the healthcare team, and learners will receive 1.0 IPCE credits for learning and change.
	Medicine CME:  Avera designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.  It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
	Nurse CE: Avera designates this activity for a maximum of 1.0 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

Avera adheres to the Joint Accreditation’s Standards for Integrity and Independence in Accredited Continuing Education.

Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.

Tuesday, January 30, 2024